Cyclic di-nucleotide induction of type I interferon Grant US-11873319-B2 United States of America 16 Jan 2024
Compositions and methods for altering second messenger signaling Grant US-11014956-B2 United States of America 25 May 2021
Compositions and methods for activating “stimulator of interferon gene”-dependent… Grant US-10653774-B2 United States of America 19 May 2020
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and… Grant US-10414789-B2 United States of America 17 Sep 2019
Compositions and methods for altering second messenger signaling Grant US-10385091-B2 United States of America 20 Aug 2019
Compositions and methods for inhibiting “stimulator of interferon gene”-dependent… Grant US-10189873-B2 United States of America 29 Jan 2019
Compositions and methods for altering second messenger signaling Grant US-10131686-B2 United States of America 20 Nov 2018
Compositions and methods for altering second messenger signaling Grant US-9840533-B2 United States of America 12 Dec 2017
Compositions and methods for cancer immunotherapy Grant US-9770467-B2 United States of America 26 Sep 2017
Compositions and methods for activating stimulator of interferon gene-dependent signalling Grant US-9724408-B2 United States of America 08 Aug 2017
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and… Grant US-9695212-B2 United States of America 04 Jul 2017
Compositions and methods for inhibiting “stimulator of interferon gene”—dependent… Grant US-9549944-B2 United States of America 24 Jan 2017
Methods for treating cancer using prostate specific antigen and tumor endothelial marker… Grant US-8557777-B2 United States of America 15 Oct 2013